Testosterone therapy deemed safe in patients with a history of prostate cancer that has been treated, and in patients with low-risk disease on active surveillance.
A recent study presented this past week at the American Urological Association Annual Meeting reveals testosterone therapy does not increase recurrence rates in men treated for prostate cancer, nor does it increase progression of prostate cancer for patients who have low-risk prostate cancer and are being managed with “active surveillance.” The study was presented by [...]